Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Abbott Labs

This article was originally published in The Gray Sheet

Executive Summary

Firm's Sof-Tact is first automated glucose monitor to offer lancing, blood collection and glucose testing, Abbott states in Nov. 20 announcement of 510(k) clearance. An alternative to fingerstick sampling methods, the diabetes management system allows for blood sampling to occur in less sensitive parts of the body such as the forearm and upper arm. Abbott will market the system as Soft-Sense in Europe
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT014159

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel